We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
651
iShares Core S&P 500 ETF
IVV
$833B
| $4.02M | 0.02% |
12,437
-287,839
| -96% | -$89.1M |
|
652
Prudential Financial
PRU
$40.4B
| $4.01M | 0.02% |
42,758
-152,171
| -78% | -$14M |
|
653
Regions Financial
RF
$24.3B
| $3.97M | 0.02% |
231,575
+1,800
| +0.8% | +$29.6K |
|
654
Cabot Corp
CBT
$4.05B
| $3.92M | 0.02% |
82,566
-600
| -0.7% | -$27.8K |
|
655
Essential Utilities
WTRG
$11.7B
| $3.92M | 0.02% |
+83,500
| New | +$3.76M |
|
|
OPLN
656
Openlane
OPLN
$4.28B
| $3.89M | 0.02% |
178,600
+112,400
| +170% | +$2.56M |
|
|
LPSN
657
DELISTED
LivePerson
LPSN
| $3.88M | 0.02% |
+7,000
| New | +$4.02M |
|
658
Tanger
SKT
$4.11B
| $3.88M | 0.02% |
263,566
| – | – |
|
659
B&G Foods
BGS
$255M
| $3.88M | 0.02% |
216,200
-6,500
| -3% | -$109K |
|
660
Factset
FDS
$9.83B
| $3.87M | 0.02% |
14,428
-80,808
| -85% | -$20.7M |
|
661
Groupon
GRPN
$786M
| $3.86M | 0.02% |
80,740
| – | – |
|
662
BorgWarner
BWA
$12.7B
| $3.82M | 0.02% |
100,093
+4,756
| +5% | +$174K |
|
663
Pricesmart
PSMT
$5.15B
| $3.8M | 0.02% |
53,507
-31,100
| -37% | -$2.24M |
|
664
PC Connection
CNXN
$2.2B
| $3.79M | 0.02% |
76,214
-3,300
| -4% | -$153K |
|
|
MRTX
665
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.74M | 0.02% |
29,051
+724
| +3% | +$69.8K |
|
|
BLD
666
DELISTED
TopBuild
BLD
| $3.74M | 0.02% |
36,300
+31,200
| +612% | +$3.25M |
|
667
Natera
NTRA
$49.8B
| $3.74M | 0.02% |
111,080
-56,635
| -34% | -$2.09M |
|
668
Arcosa
ACA
$7.13B
| $3.72M | 0.02% |
83,600
+58,600
| +234% | +$2.25M |
|
|
MSGN
669
DELISTED
MSG Networks Inc.
MSGN
| $3.72M | 0.02% |
+213,900
| New | +$3.56M |
|
670
Transmedics
TMDX
$3.04B
| $3.71M | 0.02% |
195,052
+1,114
| +0.6% | +$20.5K |
|
671
OGE Energy
OGE
$9.5B
| $3.69M | 0.02% |
83,000
+7,300
| +10% | +$315K |
|
|
MTEM
672
DELISTED
Molecular Templates, Inc.
MTEM
| $3.69M | 0.02% |
17,589
-26,776
| -60% | -$3.85M |
|
673
Huntington Ingalls Industries
HII
$11B
| $3.69M | 0.02% |
14,704
+5,891
| +67% | +$1.4M |
|
|
FSP
674
Franklin Street Properties
FSP
$34.3M
| $3.67M | 0.01% |
428,900
-2,800
| -0.6% | -$24.1K |
|
|
GMS
675
DELISTED
GMS Inc
GMS
| $3.67M | 0.01% |
+135,400
| New | +$3.97M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.